FiteBac WoundCare

Hard-to-heal wounds are one of the major complications associated with diabetes, leading to limb amputation, disability and even death. There is an urgent need for novel therapeutics that are both effective and inexpensive for patients with diabetes who have hard-to-heal wounds. K21 is a quaternary ammonium silane molecule that exhibits bactericidal, viricidal and fungicidal activity, with less toxicity and greater efficacy compared with other antiseptics such as chlorhexidine and benzalkonium chloride or antimicrobial silver. Biofilm colonization is also inhibited. As an advanced wound care product, a novel nontoxic antiseptic with immunomodulatory activity would be hugely beneficial for such patients. K21 is one such novel antiseptic.